Following is a summary of current health news briefs.
Drinking more soda and juice tied to increased diabetes risk
People who increase their consumption of sodas, juices and other sweet drinks over time are more likely than those who don't to develop diabetes, a U.S. study suggests. Researchers examined over two decades of data from more than 192,000 men and women who worked in nursing or other healthcare jobs. None of the participants had diabetes at the start of the study; by the end almost 12,000 people had developed the disease.
Stroke rates continue decline in the U.S.
Rates of stroke among U.S. adults over age 65 have steadily decreased over the past 30 years, according to a study that tracked participants from the 1980s through December 2017. Rates of decline were consistent across decades, sex and race, the study authors report in JAMA Neurology.
New York City sues online e-cigarette retailers over age verification
New York City has sued more nearly two dozen online e-cigarette retailers, accusing them of selling their products to underage New Yorkers, the city announced Wednesday. The lawsuit, filed Tuesday evening in Brooklyn federal court, targets 22 companies including Artison Vapor Franchise LLC, Eliquidstop.com and Vapor 4 Life Holdings Inc. All of them are located outside New York.
Second leading cause of death in children, firearms attract few U.S. research dollars
Few federal dollars are available for research into ways to prevent firearm injuries even though they are the second-leading cause of death among U.S. children and teens and the leading cause of death among high schoolers, a new study finds. While federal sources funded research on cancer, the third-leading cause of mortality among American youngsters, to the tune of $335 million per year, these government agencies set aside just $12 million for research into preventing firearm injuries, according to the study published in Health Affairs.
Alibaba to stop sales of e-cigarette components in United States
Chinese e-commerce firm Alibaba said on Wednesday it will stop selling e-cigarette components in the United States, amid growing regulatory scrutiny and reports of lung disease and some deaths linked to vaping. The move follows announcements by Kroger Co and Walgreens Boots Alliance Inc this week that they would stop selling e-cigarettes at their stores, in line with a similar decision by Walmart.
Humira, Rituxan top list of U.S. drugs with biggest price increases: report
AbbVie Inc's rheumatoid arthritis drug Humira and Roche Holding AG's cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on Tuesday showed. The price hikes were more than twice the rate of medical inflation and were not supported by any new clinical evidence, the Institute for Clinical and Economic Review (ICER) said in the analysis.
Trump administration to announce changes to anti-kickback rules for healthcare providers
The Trump administration will announce plans to change healthcare regulations on Wednesday to loosen anti-kickback provisions that restrict the kinds of outside services providers can refer patients to, administration officials said. President Donald Trump on Thursday will explain how the new rules advance his broader healthcare agenda, which includes reducing regulatory burdens and promoting innovative ways to reimburse healthcare providers, in a speech in Minnesota, the officials said.
China flys in 900 Danish breeding pigs to replenish herd
One of China's top pig farming companies imported 906 breeding pigs from Denmark this week, said China's customs on Wednesday, in the first import of live pigs in a year. The animals bought by C.P. Pokphand Co, China's fifth largest pig producer, arrived on a charter flight in August and spent over a month in quarantine in Xiangyang city in central Hubei province, according to a report on the website of China's General Administration of Customs.
J&J shares fall but $8 billion jury award likely to be slashed
Johnson & Johnson shares were off more than 2% on Wednesday, a day after a U.S. jury said it must pay $8 billion in punitive damages to a plaintiff in a case involving its anti-psychotic drug Risperdal, a penalty the company and others are confident will not stand. The jury in a Philadelphia court awarded the $8 billion to a man who previously won $680,000 over his claims that it failed to warn that young men using Risperdal could grow breasts.
Cracks in Purdue's proposed opioid settlement as Arizona backs out
The U.S. state of Arizona withdrew its support for a proposed nationwide opioid settlement with Purdue Pharma LP, saying the maker of OxyContin sought to "undermine material terms of the deal," according to a court filing on Monday. Since Purdue filed for bankruptcy protection in September, Arizona is the first state to switch sides in the looming showdown over the privately-held company's proposed settlement, which it has estimated is worth more than $10 billion.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)